Frankfurt (ots) – The new rules of the US Treasury were “un-American”, the acquisition of Allergan by Pfizer had been taken specifically “in the crosshairs” to Allergan CEO Brent Saunders echauffiert after the failure of the proposed 160 billion dollar takeover his company.
For Saunders is the failure of multiple bitter. The 45-year-old could already feel as a future boss of the world’s biggest pharmaceutical company. Although he was initially only become COO. But the days of the 62-year-Pfizer CEO Ian Read had been soon counted. Saunders was the crown prince. In addition, Allergan has been implicitly denounced by US Treasury Secretary Jacob Lew as series inverter and thus specifically moved into the focus of the new rules. These aim namely less on Pfizer, which could theoretically continue to venture an inverse transfer under certain conditions. Allergan, meanwhile, burned the new measures as a takeover target for large US pharmaceutical companies.
Also, Pfizer, however, is expected to carefully consider whether such a project should be approached again. First statements of Read not suggest. No wonder: Lew had equal yet ready a warning to inversion willing US companies. We will continue to look for ways to make the exodus of US companies via inverse takeovers less attractive.
So low as Allergan likely Pfizer can fail a second time. The break-up fee of 150 million dollars. Suggests that was not seriously expect a failure. The increasingly shrill nationalist tones in primaries of both parties made it President Barack Obama and but the government simply to combat tax volatile US companies. ” / p>
These are meanwhile far from the only goal of the government. On Wednesday, the US Department of Justice filed a lawsuit against the proposed acquisition of Baker Hughes by rival Halliburton. According to the government will be eliminated in a merger of the competition in many markets at 23 products and services of oilfield services. The top competition watchdog Bill Baer made the company immediately clear that he sees no chance for the takeover. “I’ve never seen a deal that raises so many antitrust problems in so many markets.”
The M & amp <- - sh_cad_5!>; A market has to adjust well to intensified resistance. In recent months the Obama presidency, the US government probably knows no mercy
OTS. <- - Sh_cad_6!>: Börsen-Zeitung newsroom: http://www.presseportal.de/nr / 30377 newsroom via RSS: http://www.presseportal.de/rss/pm_30377.rss2
